Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.

about

Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.

Item

http://www.wikidata.org/entity/Q38633640

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Expression of CD70 (CD27L) Is ...... in IDH-Wild-Type Glioblastoma.

@en

type

Item

label

Expression of CD70 (CD27L) Is ...... in IDH-Wild-Type Glioblastoma.

@en

prefLabel

Expression of CD70 (CD27L) Is ...... in IDH-Wild-Type Glioblastoma.

@en

P1476

Expression of CD70 (CD27L) Is ...... in IDH-Wild-Type Glioblastoma

@en

P2093

Drew Pratt

http://www.w3.org/2001/XMLSchema#string

Liqiang Xi

http://www.w3.org/2001/XMLSchema#string

Mark R Gilbert

http://www.w3.org/2001/XMLSchema#string

Mark Raffeld

http://www.w3.org/2001/XMLSchema#string

Martha Quezado

http://www.w3.org/2001/XMLSchema#string

Patricia Fetsch

http://www.w3.org/2001/XMLSchema#string

Stefania Pittaluga

http://www.w3.org/2001/XMLSchema#string

P2860

CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The 2007 WHO classification of tumours of the central nervous system

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Chimeric antigen receptor T cells for sustained remissions in leukemia

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma

P304

697-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/NLX051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maryknoll Palisoc

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28789475

http://www.w3.org/2001/XMLSchema#string

P932

6251514

http://www.w3.org/2001/XMLSchema#string